Total Payments
$33,889
2024 Payments
$14,827
Companies
37
Transactions
889
Medicare Patients
5,007
Medicare Billing
$398,273
Payment Breakdown by Category
Food & Beverage$20,255 (59.8%)
Consulting$11,700 (34.5%)
Education$1,081 (3.2%)
Travel$852.90 (2.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $20,255 | 871 | 59.8% |
| Consulting Fee | $11,700 | 2 | 34.5% |
| Education | $1,081 | 15 | 3.2% |
| Travel and Lodging | $852.90 | 1 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| MERZ NORTH AMERICA, INC. | $12,306 | 23 | $0 (2024) |
| ABBVIE INC. | $3,893 | 179 | $0 (2024) |
| Janssen Biotech, Inc. | $2,256 | 92 | $0 (2024) |
| Medimetriks Pharmaceuticals, Inc. | $1,873 | 6 | $0 (2021) |
| Galderma Laboratories, L.P. | $1,713 | 65 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,500 | 88 | $0 (2024) |
| GENZYME CORPORATION | $1,356 | 53 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,033 | 51 | $0 (2024) |
| Lilly USA, LLC | $928.05 | 39 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $916.35 | 41 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $14,827 | 184 | MERZ NORTH AMERICA, INC. ($11,173) |
| 2023 | $3,756 | 155 | ABBVIE INC. ($1,026) |
| 2022 | $4,046 | 186 | ABBVIE INC. ($578.74) |
| 2021 | $4,361 | 128 | Medimetriks Pharmaceuticals, Inc. ($1,862) |
| 2020 | $1,914 | 85 | GENZYME CORPORATION ($233.08) |
| 2019 | $2,065 | 50 | AbbVie, Inc. ($385.14) |
| 2018 | $1,305 | 40 | AbbVie, Inc. ($323.33) |
| 2017 | $1,616 | 61 | Janssen Biotech, Inc. ($478.27) |
All Payment Transactions
889 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | MERZ NORTH AMERICA, INC. | Xeomin | Consulting Fee | Cash or cash equivalent | $9,900.00 | General |
| 12/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $31.56 | General |
| Category: Immunology | ||||||
| 12/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.51 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Education | In-kind items and services | $8.45 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $29.66 | General |
| Category: Immunology | ||||||
| 12/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Immunology | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $8.70 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: DERMATOLOGY | ||||||
| 12/05/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $10.21 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $11.71 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Immunology | ||||||
| 11/27/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $32.35 | General |
| Category: Immunology | ||||||
| 11/26/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $21.98 | General |
| Category: Immunology | ||||||
| 11/22/2024 | MERZ NORTH AMERICA, INC. | Xeomin | Travel and Lodging | In-kind items and services | $852.90 | General |
| 11/21/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $7.61 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $109.01 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $31.70 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $30.62 | General |
| Category: Inflammation | ||||||
| 11/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $9.81 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: Dermatology | ||||||
| 11/06/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $7.55 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $25.82 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $11.18 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 751 | 1,366 | $159,096 | $37,173 |
| 2022 | 15 | 1,583 | 3,755 | $406,312 | $131,986 |
| 2021 | 14 | 1,324 | 3,204 | $312,575 | $104,499 |
| 2020 | 17 | 1,349 | 3,100 | $370,583 | $124,615 |
Total Patients
5,007
Total Services
11,425
Medicare Billing
$398,273
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 165 | 195 | $36,302 | $7,634 | 21.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 95 | 113 | $29,719 | $6,731 | 22.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 102 | 113 | $26,536 | $6,665 | 25.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 142 | 167 | $23,149 | $4,387 | 19.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 48 | 51 | $10,480 | $2,955 | 28.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 120 | 641 | $8,886 | $2,670 | 30.0% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 20 | 24 | $8,683 | $2,319 | 26.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $8,598 | $1,934 | 22.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 22 | 22 | $5,151 | $1,316 | 25.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 12 | 15 | $1,590 | $561.47 | 35.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 318 | 489 | $86,468 | $27,501 | 31.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 174 | 282 | $70,714 | $24,197 | 34.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 171 | 222 | $49,334 | $17,708 | 35.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 256 | 405 | $53,159 | $13,673 | 25.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 142 | 177 | $35,514 | $11,139 | 31.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 208 | 1,789 | $23,825 | $8,479 | 35.6% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 48 | 64 | $21,228 | $7,618 | 35.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 69 | 69 | $22,356 | $6,936 | 31.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 73 | 73 | $15,746 | $4,296 | 27.3% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2022 | 11 | 11 | $9,260 | $3,647 | 39.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 36 | 56 | $5,584 | $2,220 | 39.8% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 11 | 14 | $4,742 | $1,796 | 37.9% |
| 10060 | Simple or single drainage of skin abscess | Office | 2022 | 20 | 21 | $5,137 | $1,767 | 34.4% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2022 | 22 | 28 | $3,119 | $959.53 | 30.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 24 | 55 | $127.40 | $47.61 | 37.4% |
About Dr. Milton Moore, M.D
Dr. Milton Moore, M.D is a Internal Medicine healthcare provider based in San Antonio, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/10/2011. The National Provider Identifier (NPI) number assigned to this provider is 1871888545.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Milton Moore, M.D has received a total of $33,889 in payments from pharmaceutical and medical device companies, with $14,827 received in 2024. These payments were reported across 889 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($20,255).
As a Medicare-enrolled provider, Moore has provided services to 5,007 Medicare beneficiaries, totaling 11,425 services with total Medicare billing of $398,273. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Dermatology
- Location San Antonio, TX
- Active Since 06/10/2011
- Last Updated 10/16/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1871888545
Products in Payments
- Clindacin ETZ (Drug) $1,862
- DUPIXENT (Biological) $1,776
- TREMFYA (Drug) $1,605
- SKYRIZI (Biological) $1,475
- RINVOQ (Biological) $1,042
- COSENTYX (Biological) $1,019
- Sotyktu (Drug) $916.35
- Humira (Biological) $857.96
- Xeomin (Biological) $835.63
- TALTZ (Drug) $803.89
- OPZELURA (Drug) $630.58
- COSENTYX (Drug) $428.08
- DUPIXENT (Drug) $374.34
- STELARA (Biological) $372.77
- AKLIEF (Drug) $347.55
- Otezla (Drug) $344.51
- DUPIXENT DUPILUMAB INJECTION (Biological) $319.03
- ILUMYA (Biological) $302.67
- REMICADE (Biological) $286.61
- DORYX (Drug) $273.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in San Antonio
Hemal Nayak, Md, MD
Internal Medicine — Payments: $642,605
Internal Medicine $642,605
Dr. Allen Anderson, Md, MD
Internal Medicine — Payments: $444,990
Internal Medicine $444,990
Montaser Shaheen, M.d, M.D
Internal Medicine — Payments: $300,958
Internal Medicine $300,958
Shahid Aziz, M.d, M.D
Internal Medicine — Payments: $281,598
Internal Medicine $281,598
Dr. Ali Abedi, M.d, M.D
Internal Medicine — Payments: $257,382
Internal Medicine $257,382
Dr. Manuel Rodriguez, M.d, M.D
Internal Medicine — Payments: $187,632
Internal Medicine $187,632